You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for New Drug Application (NDA): 017810


✉ Email this page to a colleague

« Back to Dashboard


NDA 017810 describes PROSTIN E2, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the PROSTIN E2 profile page.

The generic ingredient in PROSTIN E2 is dinoprostone. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dinoprostone profile page.
Summary for 017810
Tradename:PROSTIN E2
Applicant:Pfizer
Ingredient:dinoprostone
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017810

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;VAGINALStrength20MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 017810

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PROSTIN E2 dinoprostone SUPPOSITORY;VAGINAL 017810-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Pfizer PROSTIN E2 dinoprostone SUPPOSITORY;VAGINAL 017810-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.